PharmaBlock Convenes Global Industry Leaders in Zurich to Advance Green Chemistry for Sustainable Pharmaceutical Manufacturing
ZURICH, July 20, 2026 /PRNewswire/ -- As Europe experienced one of its hottest Junes on record, with prolonged heatwaves reinforcing the urgency of climate action, leaders from the pharmaceutical industry and academia gathered in Zurich for the...
BIOHK2026 (Hong Kong International Biotechnology Conference and Exhibition), 9-12 September, Hong Kong - Connecting Global Leaders in Biotechnology
Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September. HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong Kong International Biotechnology Conference and...
IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Despite challenging framework conditions such as high energy prices, the international introduction of tariffs, and bureaucratic requirements, Saxony-Anhalt is drawing a positive balance for 2025: leading companies have announced or begun...
NYSE Content Advisory: Pre-Market update + Wall Street reopens after Juneteenth
NEW YORK, June 20, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content...
Clarivate Report Reveals Top Trademark Portfolios
Procter & Gamble, Nestle, Apple, L'Oreal, Novartis, LG Electronics and Unilever among the largest portfolio owners in most registers LONDON, May 15, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative...
Appian Celebrates 2025 Innovation Award Winners
Customers Delivered Value with Process Orchestration and AI Capabilities on the Appian Platform SYDNEY, April 30, 2025 /PRNewswire/ -- Appian (Nasdaq: APPN) today announced the 2025 Appian Innovation Awards winners at Appian World, its annual global...
Docquity and Novartis Partner to Tackle Retinal Health Challenges in Malaysia
The multi-year collaboration leverages Docquity's Awareness to Advocacy (A2A) Program to expand retinal health education amongst thousands of HCPs and widen access to retinal health products With 81.5% of Southeast Asian doctors participating in...